RxSight (RXST) Interest & Investment Income (2020 - 2026)

RxSight (RXST) has reported Interest & Investment Income for 7 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest & Investment Income fell 21.74% year-over-year to $1.8 million; the trailing twelve-month figure through Jun 2026 stood at $8.3 million (down 20.11% YoY), and the FY2025 full-year result was $9.3 million, down 1.5% from the prior year.
• Interest & Investment Income fell to $1.8 million in Q2 2026 per RXST's latest filing, from $2.0 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $2.9 million in Q3 2024 and bottomed at $46000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $1.7 million across 5 years, with a median of $1.8 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Interest & Investment Income jumped 8260.0% in 2022, then dropped 22.09% in 2026.
• Over 5 years, Interest & Investment Income stood at $836000.0 in 2022, then jumped by 98.68% to $1.7 million in 2023, then surged by 62.97% to $2.7 million in 2024, then declined by 18.91% to $2.2 million in 2025, then dropped by 19.64% to $1.8 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $1.8 million, $2.0 million, and $2.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.